Brief: Kane Biotech Inc Reports Q1 Loss Per Share Of $0.008
22/05/2019 22:26
May 22 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES FIRST QUARTER 2019 FINANCIAL
RESULTS,
EXTENSION OF LOAN AND INSIDER FUNDING
* KANE BIOTECH INC - BETWEEN OCTOBER, 2018 AND MAY, 2019 IT
HAS
RECEIVED A TOTAL OF $1.35 MILLION IN OPERATING ADVANCES FROM
INSIDERS AND THEIR ASSOCIATES
* KANE BIOTECH INC - QTRLY LOSS PER SHARE $0.008
Source text for Eikon: ID:nGNXrYzYx
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update